JBI-802: the first orally available LSD1/HDAC6 dual inhibitor to enter clinical trials
{{output}}
Introduction: Lysine-specific demethylase 1 (LSD1) and histone deacetylase 6 (HDAC6) are key epigenetic regulators involved in histone demethylation and deacetylation, processes that impact chromatin structure and gene expression... ...
